- Built to Serve: The Day That Reminds Us Why We Chose Dentistry
- Journalists Catch You Up on Fauci Hearing, Peptides, and Kids’ Caffeine Consumption
- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- Nebraska launches dashboard tracking rural health funds
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
Michigan healthcare freedom community forum
Several business news outlets are reporting that the board of Rite Aid is considering another bankruptcy:
Rite Aid weighs repeat bankruptcy filing, WSJ reports
By Reuters - April 4, 2025April 4 (Reuters) - U.S. pharmacy chain Rite Aid is weighing a possible repeat bankruptcy after its recent financial restructuring failed to put the drugstore chain on a sustainable path, the Wall Street Journal reported on Friday.
The company has also been pursuing a sale of some or all of its businesses as a potential alternative to a Chapter 11 filing, the WSJ report said, citing people familiar with the matter.
If a sale doesn't materialize either inside or outside of bankruptcy, the pharmacy chain stands at risk of liquidating more of its footprint, the report added.
Rite Aid did not immediately respond to a Reuters request for comment.
The Pennsylvania-based company emerged from Chapter 11 bankruptcy and successfully completed its financial restructuring last year, operating as a private company.
The pharmacy has used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir and negotiate settlements with its lenders, drug distribution partner McKesson (MCK.N), opens new tab and other creditors.
Rite Aid filed for Chapter 11 in October 2023, after reporting $750 million in losses and $24 billion in revenue for the fiscal year ended March 2023. It operated 2,000 pharmacies at the time of its bankruptcy.
Rite Aid says it plans to keep its 1,350 stores in 15 states open, but this may be the end for the 63 year old chain: despite filing for bankruptcy again.
https://www.upi.com/Top_News/US/2025/05/05/Rite-Aid-bankruptcy-again/2311746482815/
Rite Aid files for bankruptcy for second time in 18 months
By Allen Cone - May 5, 2025May 5 (UPI) -- Rite Aid on Monday announced it is filing for bankruptcy and looking for a new buyer, just seven months after exiting Chapter 11.
Eighteen months ago, Rite Aid first filed for bankruptcy in October 2023 because it couldn't compete against bigger chains and paid millions for filling unlawful opioid prescriptions. The company plans to keep open its 1,350 stores in 15 states with 4,000 employees.
"For more than 60 years, Rite Aid has been a proud provider of pharmacy services and products to our loyal customers," Matt Schroeder, Rite Aid's CEO, said a statement. "While we have continued to face financial challenges, intensified by the rapidly evolving retail and healthcare landscapes in which we operate, we are encouraged by meaningful interest from a number of potential national and regional strategic acquirers.
"As we move forward, our key priorities are ensuring uninterrupted pharmacy services for our customers and preserving jobs for as many associates as possible."
Rite Aid secured $1.9 billion in new financing, along with cash from operations, and is expected to provide sufficient funding during the sale and court-supervised process," according to a Rite Aid release.
The company intends to divest or monetize any assets not sold through the court-supervised process.
During the first Chapter 11 process, the company slashed $2 billion in debt, secured $2.5 billion in funds to keep operating and closed about 500 locations.
Rite Aid, which is headquartered in Philadelphia, had revenue of $24.06 billion in 2023 but a $750 million net loss, according to its filing.
Rite Aid is the third-largest nationwide standalone pharmacy chain in the United States far behind CVS's 9,118 and Walgreens with 8,363. CVS also has 1,865 retail pharmacies within retail chains and approximately 80 clinics in Target stores.
When counting big box chains, such as Walmart, it is the seventh-largest pharmacy in the United States. Also Amazon is now selling prescription drugs.
In 2015, Walgreens offered $17 billion to acquire the company, but U.S. regulators were fearful the combination would violate federal antitrust laws and reduce competition in the market.
In 2017, the companies agreed to a $4.4 billion deal in which Walgreens acquired 1,932 of the 4,000 Rite Aid locations.
Rite Aid's peak in 2008 was 5,059 stores. Rite Aid opened its first store in 1962 in Scranton, Pa., and now is mainly in New York, California and Pennsylvania.
Walgreens announced in March that it was going private in a deal valued up to $24 billion. The transaction is expected to be finalized later this year.
CVS has closed more than 1,000 stores and undergone thousands of layoffs.
Rite Aid has begun selling off its "pharmacy assets". In some cases entire stores, in others prescription and customer files:
Rite Aid to sell 1,000 pharmacy assets to CVS, Walgreens and others
By Sabrina Valle - May 15, 2025May 15 (Reuters) - Bankrupt U.S. pharmacy chain Rite Aid on Thursday said it agreed to sell pharmacy assets from more than 1,000 store locations in separate transactions to CVS Pharmacy, Walgreens, Albertsons, Kroger and Giant Eagle, among others.
CVS Pharmacy will buy and operate many Rite Aid and Bartell Drugs stores in Washington, Oregon and Idaho, Rite Aid said in a filing.
Rite Aid stores will remain open, and customers can continue to use pharmacy services, including prescription refills and immunizations, without interruption, it said.
The sale includes prescription files and other goods, a person familiar with the agreements said.
Walgreens declined to comment. The other bidders did not immediately respond to requests for comment.
Earlier this month, Rite Aid filed for bankruptcy for the second time in less than two years, after poor performance in its retail business made it difficult for the company to maintain sufficient cash flow and restock its retail inventory.
The company has received court approval to pursue a rapid-fire sale of its pharmacy business. Rite Aid is scheduled to conduct a hearing to approve the sales on May 21. The sales will remain subject to regulatory notices and approvals.
The Pennsylvania-based company entered bankruptcy with over $2 billion in debt and has warned employees about likely job cuts. Rite Aid Chief Executive Matt Schroeder said on Thursday the company would try to preserve jobs during the transition.
"These agreements ensure our pharmacy customers will experience a smooth transition while preserving jobs for some of our valued team members," Schroeder said in a note.
Bloomberg had previously reported on CVS' bid.
Rite Aid had about 1,350 pharmacies, so the fate of the remaining 350 pharmacies is yet to be explained.
And they're gone for good:
https://www.cbsnews.com/news/rite-aid-closing-all-locations-after-decades-in-business/
Rite Aid closing all locations after decades in business
October 4, 2025 / 9:34 PM EDT / CBS NewsRite Aid is closing all locations, according to a recent post on the U.S. pharmacy chain's website.
"All Rite Aid stores have now closed. We thank our loyal customers for their many years of support," read a post at the bottom of the Rite Aid website.
CBS News reached out to Rite Aid for comment on Saturday.
Rite Aid filed for bankruptcy in May, the second such filing in nearly two years. The company also filed for bankruptcy in October 2023 and said at the time that the restructuring would "significantly reduce the company's debt" while helping to "resolve litigation claims in an equitable manner." Rite Aid said it planned to close down 154 stores after the filing.
The company obtained $3.45 billion in fresh financing as it carried out a restructuring plan and dealt with dips in sales and opioid-related lawsuits.
More than 520 Rite Aid pharmacies have closed since October 2023, which is about a quarter of the 2,111 open at the time of the bankruptcy filing.
The Justice Department filed a complaint against Rite Aid in March 2023, accusing the company of violating the False Claims Act and the Controlled Substances Act by filling unlawful prescriptions for drugs such as oxycodone, fentanyl and benzodiazepine and ignoring internal red flags about the prescriptions, CBS News reported.
The website for the company founded in 1962 now only shows a service to help former customers find a new pharmacy and a link to request pharmacy records.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















